HIF1A and breast carcinoma: A liposomal nano-formulation delivering the Fenton’s catalyst, copper oleate, and the HIF-1 inhibitor, acridinium flavonoids (ACF), has been reported to be useful for breast cancer treatment, which further emphasizes the role of HIF-1α in the regulation of BC (Guo et al., 2021).